Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance Syros’ Ongoing Clinical ProgramsSyros Expects to Have Cash Into 2025; At Least a Year Past SELECT-MDS-1 Pivotal DataNow Planning to Initiate Phase 3 Clinical Trial of SY-2101 in APL 2H 2023Syros to Host Conference Call at 8:30 AM ET Today.
NewsNow: US Health news | Breaking News & Search 24/7 newsnow.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsnow.co.uk Daily Mail and Mail on Sunday newspapers.